June 20 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* ANNOUNCES INTENTION TO PROCEED WITH PRIVATE PLACEMENT
* ANNOUNCES ITS INTENTION TO PROCEED WITH AN EQUITY RAISE
FOR AN
AGGREGATE MINIMUM AMOUNT OF EUR 20 MILLION VIA A PRIVATE
PLACEMENT OF NEW ORDINARY SHARES WITH CERTAIN PROFESSIONAL,
QUALIFIED, INSTITUTIONAL AND OTHER PRIVATE INVESTORS ONLY
* TRADING IN MITHRA SHARES ON EURONEXT BRUSSELS WILL BE
SUSPENDED
UNTIL THE FINAL DETAILS OF THE CONTEMPLATED PRIVATE PLACEMENT
ARE ANNOUNCED
* FURTHERMORE, THE COMPANY INTENDS TO PURSUE AND ACCELERATE
A COST
REDUCTION PROGRAMME TO IMPROVE THE CASH RUNWAY AND PERFORMANCE
OF THE COMPANY
* COMPANY HAS ALREADY OBTAINED SUBSCRIPTION COMMITMENTS FROM
CERTAIN EXISTING SHAREHOLDERS FOR AN AGGREGATE AMOUNT OF EUR
21.9 MILLION
* CUSTOMARY CORPORATE PROCEDURES AND CONDITIONS PRECEDENT
ARE
EXPECTED TO BE COMPLETED ON OR ABOUT THURSDAY 23 JUNE 2022
* INTENDS TO ANNOUNCE FINAL DETAILS AND CONDITIONS OF
PRIVATE
PLACEMENT IN A SUBSEQUENT PRESS RELEASE
* FINANCING IS EXPECTED TO BE CONVERTIBLE IN NEW SHARES OF
THE
COMPANY AT THE OPTION OF THE LENDERS
* THE FINANCING IS STILL SUBJECT TO DISCUSSION, NEGOTIATION
AND
COMPLETION OF CERTAIN CONDITIONS PRECEDENTS, AND IT CANNOT BE
GUARANTEED THAT THE FINANCING CAN BE COMPLETED AS AFOREMENTIONED
* IS CURRENTLY IN EXCLUSIVE NEGOTIATIONS IN RESPECT OF
SECURED
CONVERTIBLE LOAN FOR PRINCIPAL AMOUNT OF UP TO EUR 100 MILLION
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))